According to reports, the human clinical trial of India'sfirst, possible anti-COVID vaccine 'Covaxin' began at an institute here onMonday.
The human trial of the coronavirus vaccine has begun at theInstitute of Medical Sciences and SUM Hospital in Bhubaneswar.
Covaxin has been administered to several volunteers,informed E.Venkat Rao, Principal Investigator of the trial process.
The volunteers went under a thorough screening procedure andseveral tests, he added.
SUM Hospital is one of the 12 centres selected by IndianCouncil of Medical Research (ICMR) for conducting phase one and two of theprocess.
Covaxin is being developed by Bharat Biotech incollaboration with the ICMR and the National Institute of Virology (NIV).
IMS and SUM Hospital is the only medical institute in Odishawhich is conducting a clinical trial of the vaccine.